Neurocrine Biosciences (NBIX) Tops Q3 EPS by 58c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $164.18 --0%
Revenue Growth %: +26.4%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +26.4%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $2.17, $0.58 better than the analyst estimate of $1.59. Revenue for the quarter came in at $794.9 million versus the consensus estimate of $748.62 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- Mizuho Reiterates Outperform Rating on Darden Restaurants (DRI)
- Active options: META IREN NFLX AMD SOFI BB GOOGL QCOM NOK
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
